Eli Lilly CEO, Off The Charts, & Lessons Learned In Biotech

The Dow closed up 31 points hitting another all-time high and Cramer’s digging into today’s biggest movers. Then, the drug companies have been caught in political crosshairs, and Cramer’s getting to the core of it with Eli Lilly’s CEO. And, with the market at all-time highs, are there any bargains out there? Cramer’s going off the charts to look at bargain buys during market highs. And you’ve called in and stumped Professor Cramer, and tonight he’s turning in his homework on Wave Life Sciences and sharing what lessons he has learned through his research into speculative biotech names. 

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.